Abstract

BackgroundTo evaluate the prognostic role of TAMs in patients affected by non-muscle invasive bladder cancer (NMIBC), undergone Trans Urethral Resection of Bladder (TURB) and Bacillus Calmette-Guerin (BCG) therapy.MethodsData from 40 patients (36 men, 4 women), mean age 69 years (40-83 years), treated for NMIBC with TURB and BCG instillation were collected. Two different groups were considered: group with and group without bladder cancer recurrence. Correlations between immunofluorescence measured Mtot, M1 and M2 infiltration and clinicopathological parameters were evaluated using Spearman and Mann–Whitney methods. The recurrence-free survival rate was calculated using the Kaplan-Meier method.ResultsCD68 positive cells (Mtot) were observed in all specimens tested. High Mtot, M1 and M2 infiltration was observed in patients with disease recurrence, even before endovescical BCG instillation. Significant value for M2 infiltration (p = 0,042) was found calculating significativity between two group medians before BCG therapy. p = 0,072 and p = 0,180 were observed correlating median of Mtot and M1 between two groups of patients respectively. Values of p = 0,44, p = 0,23 and p = 0,64 from correlation between DFS and Mtot, M1 and M2 median in patients before endovescical BCG instillation, were calculated respectively. Comparing DFS and Mtot, M1 and M2 median in patients group after endovescical BCG instillation significant values were obtained (p = 0,020; p = 0,02; and p = 0,029 respectively).ConclusionsM2 tumor infiltration could be a prognostic value of recurrence in patients with NMIBC.

Highlights

  • To evaluate the prognostic role of therapy for highTumor-associated macrophages (TAMs) in patients affected by non-muscle invasive bladder cancer (NMIBC), undergone Trans Urethral Resection of Bladder (TURB) and Bacillus Calmette-Guerin (BCG) therapy

  • M2 tumor infiltration could be a prognostic value of recurrence in patients with NMIBC

  • Considering two patient populations we found a different M1 and M2 infiltration (Tables 1 and 2)

Read more

Summary

Introduction

To evaluate the prognostic role of TAMs in patients affected by non-muscle invasive bladder cancer (NMIBC), undergone Trans Urethral Resection of Bladder (TURB) and Bacillus Calmette-Guerin (BCG) therapy. Urothelial bladder cancer is the second cancer for incidence of urinary tract. Bladder cancer is responsible of 4.1% cancercorrelated death in men and 1.8% in women [1]. 75% of urothelial bladder cancer are non-muscle invasive (NMIBC) at diagnosis [2]. Standard therapy for NMIBC includes trans-urethral resection of tumor, followed by endovescical instillation of chemo- / immuno-therapy for high. Tumor-associated macrophages (TAMs) represent a substantial fraction of the growing tumor mass and are associated with poor prognosis in several human cancers [8]. M1 macrophages show a protective role in tumor-genesis activating tumor-killing mechanisms and antagonizing the activities of M2

Methods
Results
Conclusion

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.